Chronic gastroenterological disease and hepato-biliary-pancreatic diseases
Conditions
Interventions
None listed
Sponsors
Department of Gastroenterology and Hepatology Okayama University Graduate School of Medicine, Dentistry, and Pharamaceutical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Chronic gastroenterological and hepato-biliary-pancreatic disease patients who met following criteria and obtained written informed consent. 1)Chronic gastroenterological and hepato-biliary-pancreatic disease patients (Chronic inflammatory disease 110, Cancer patients110) 2) 20 years of age or more.
Exclusion criteria
Exclusion criteria: Key exclusion criteria; 1) Patients who decided not suitable by the physicians. 2) Age less than 20 and patients who can not undestand the protocol.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Microbiome and Metabolome analysis for disease condition: The gut and the oral cavity microbiome analysis and metabolome analysis will be performed. The correlation between disease condtion and the specific microbiota and/or metabolite will be analyzed. | — |
Secondary
| Measure | Time frame |
|---|---|
| Microbiome and Metabolome anaysis for laboratory data: Age, Liver related data;AST,ALT,gGTP,Alb,Total bilirubin Diabetes related data;FPG,IRI,HbA1c Tumor markers;CEA,CA125,CA19-9,SCC,CK19 Autoantibodies;ANA,IgG | — |
Countries
Japan
Contacts
Public ContactAkinobu Takaki
Okayama University Graduate School of Medicine, Dentistry, and Pharamaceutical Sciences Department of Gastroenterology and Hepatology
Outcome results
None listed